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Figure 2
Conclusions: Mechanical injury potentiated the catabolic response induced by TNF-α at the transcript level (data not shown). Short term glucocorticoid treatment effectively abolished the catabolic effects of TNF-α plus injury, preventing both proteoglycan degradation and biosynthesis reduction. Ongoing studies focus on identifying the effects of dexamethasone on expression of inflammatory cytokines and enzymes at the transcript level.
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PUTATIVE 3D HUMAN TISSUE MODEL FOR OSTEOARTHRITIS
L. Sun, D.L. Kaplan Tufts Univ., Medford, MA Purpose: Osteoarthritis is a major cause of disability during aging. While the mechanisms involved in osteoarthritis are not yet clear, animal models and cell lines are most often used as disease models. However, inherent limitations with these approaches prompt the need for improved options using human tissue systems. A relevant tissue engineering osteoarthritis model in vitro would allow more insight into underlying mechanisms and would also provide a useful platform for drug screening. Methods: Tissue engineered (TE) cartilage was prepared by using silk-derived porous 3D scaffolds seeded with primary human chondrocytes and culturing in chondrogenic medium for 4 weeks. The TE cartilage mimicked cartilage in terms of many aspects of cell and matrix features. An osteoarthritis-like phenotype was induced by culturing the cells with cytokines, a combination of IL-1β, and TNF-α, or culturing the cells with conditioned medium from THP-1 derived macrophages. The later served to generate a broad spectrum of cytokines to represent the infiltration of macrophages in vivo. The systems were studied for up to 5 weeks in a static culture. Results: After 1 week with cytokines induction, matrix anabolismrelated genes such as ACAN (GAG) and Col II were dramatically down-regulated; while at the same time genes for matrix catabolism-related enzymes, such as MMP13, ADAMTS4, were up-regulated. As a marker of aging and calcification in osteoarthritis, the Col X gene was up-regulated 7-fold when compared to the untreated (control) group. The data indicated that chondrocytes responded to the cytokine stimulation in these 3D cultures and matrix turnover was initiated, in as a mimic of the disease condition. After 3 weeks, chondrocyte apoptosis was found in the TE cartilage, with a higher or dose response effect when the TE cartilage system was treated with a higher dose of cytokines. Collagen type X expression was confirmed by immunohistology. For TE cartilage treated with conditioned medium from the macrophages, the results and trends were similar to those with the cytokine treated group, except for some differences in magnitude of response in matrix-related gene expression. This difference may due to the complex components present in this conditioned media besides IL-1β and TNF-α. Conclusions: Silk porous scaffolds provided a compatible environment for three-dimensional tissue engineered cartilage. In the presence of cytokines or conditioned medium from macrophages, TE cartilage showed osteoarthritis-like phenotypes, with results generally consistent with previous clinical studies. This approach may serve as a suitable starting point to generate relevant and useful in vitro osteoarthritis models. Purpose: Alkaptonuria (AKU) is a rare autosomal recessive condition resulting from lack of homogentisate 1,2 dioxygenase (HGD), the enzyme responsible for the breakdown of homogentisic acid (HGA). HGA accumulates in body tissues resulting in ochronosis, the deposition of pigmented HGA polymers that have high affinity for collagenous tissues, primarily articular cartilage of the weight bearing joints. Over time, pigmentation leads to severe joint degeneration presenting as osteoarthritis. The aim of this study was to use light and transmission electron microscopy (TEM) to identify the location of ochronotic pigment in joint tissues in vivo and in an in vitro model. Methods: Tissues were collected at the time of surgery from AKU patients undergoing joint surgery. C20-A4 transformed human chondrocytes and SaOS-2 osteosarcoma cells were cultured in DMEM in the presence or absence of 0.33×10 -4 M HGA. All samples were processed routinely for histology and TEM. Paraffin sections were stained with either H&E or nuclear fast red and Schmorl's reagent to highlight pigment. TEM samples were post stained using uranyl acetate and lead citrate. Results: Macroscopic examination of AKU tissues revealed intense pigmentation of articular cartilage. Synovial and capsular tissues had pigmented and non-pigmented areas. Bone was almost devoid of pigmentation. H&E staining of surgical tissues demonstrated pigment intra-and extracellularly. Chondrocytes, fibroblasts and osteocytes all contained pigment. Ochronotic pigment was located among collagen fibres in articular cartilage, capsule and synovium. Pigment was absent in mineralised collagen fibres of bone. Schmorl's reagent demonstrated smaller amounts of pigment attached to the collagen fibres, undetected using H&E. Schmorl's staining of in vitro cultures revealed pigment deposits both intraand extracellularly. Ultrastructural examination of tissue samples revealed pigment deposition on collagen fibres in cartilage and capsule; in some regions pigment was easily identifiable bound to collagen, whereas others had no pigment. Ultrastructural distribution differed between capsule and cartilage. Pigment in capsule was associated with the collagen fibril periodicity and was also found in the body of collagen fibres. However, in cartilage there were some areas similar to capsule but pigmentation was also present as large amorphous granules not associated with collagen fibres. Examination of the in vitro model clearly showed association of pigment with extracellular fibres of chondrocytes and osteosarcoma cells, as well as intracellular when cultured in HGA. Pigment was absent in control cultures.
ULTRASTRUCTURAL ANALYSIS OF COLLAGEN IN THE
Conclusions:
We have detected distinctive patterns of ochronotic pigment deposition in the ECM of joint tissues in AKU. We have also produced and analysed an in vitro model of ochronosis that replicates pigment deposition in 7 days, whereas in vivo pigmentation takes many years to appear. This model should facilitate the analysis of the molecular mechanism of pigment deposition and help in the development of therapeutic strategies to prevent ochronosis and subsequent arthopathies. We have also shown that mineralisation of collagen in bone protects against ochronosis. sion on NFκB activation and IκB-α gene expression in chondrocyte/agarose constructs Methods: Chondrocyte/agarose constructs were cultured under free-swelling conditions or subjected to dynamic compression (15%, 1 Hz) for up to 360 min with IL-1β and/or PDTC (inhibits NFκB activation). Nuclear translocation of NFκB-p65 was analysed by imunofluoresence microscopy. Gene expression of IκB-α, iNOS, IL-1β and IL-4 were assessed by real-time qPCR coupled with molecular beacons. Statistical analysis for fluorescent intensity data was performed using the non-parametric Mann-Whitney U-test to compare data between treatment groups. For studies involving gene expression, we performed a logarithmic transformation of ratio values prior to analysis by a two-way ANOVA and the post hoc Bonferroni-corrected t-test and compared differences between unstrained and strained constructs for the different treatment groups. Results: Nuclear translocation of NFκB-p65 was concomitant to an increase in nuclear fluorescence intensity which reached maximal values at 60 min with IL-1β(p<0.001). The application of dynamic compression or presence of the NFκB inhibitor, PDTC reduced nuclear fluorescence and NFκB nuclear translocation in cytokine treated constructs (p<0.001 and p<0.01, respectively, Fig. 1 ). IL-1β increased IκB-α expression (p<0.001) at 60 min and either induced iNOS (p<0.001) and IL-1β (p<0.01) or inhibited IL-4 (p<0.05) expression at 360 min. These time-dependent gene expression events were partially reversed by dynamic compression or the presence of PDTC (p<0.01, Fig. 2 ) in IL-1β treated constructs. However, co-stimulation by dynamic compression and PDTC favoured suppression (IκB-α, iNOS, IL-1β) or induction (IL-4) of gene expression (Fig. 2) . Conclusions: This study explored the potential of IL-1β and dynamic compression to influence NFκB activation and expression of IκB-α in chondrocyte/agarose constructs. IL-1β increased NFκB-
